Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of sitagliptin added to ongoing metformin and rosiglitazone combination therapy in a randomized placebo-controlled 54-week trial in patients with type 2 diabetes.
Dobs AS, Goldstein BJ, Aschner P, Horton ES, Umpierrez GE, Duran L, Hill JS, Chen Y, Golm GT, Langdon RB, Williams-Herman DE, Kaufman KD, Amatruda JM, Ferreira JC. Dobs AS, et al. Among authors: aschner p. J Diabetes. 2013 Mar;5(1):68-79. doi: 10.1111/j.1753-0407.2012.00223.x. J Diabetes. 2013. PMID: 22742523 Clinical Trial.
Glycemic status and health-related quality of life (HRQOL) in populations at risk of diabetes in two Latin American cities.
Anillo Arrieta LA, Flórez Lozano KC, Tuesca Molina R, Acosta Vergara T, Rodríguez Acosta S, Aschner P, Diaz Montes Y, Nieto Castillo JP, Florez-Garcia VA, Barengo NC. Anillo Arrieta LA, et al. Among authors: aschner p. Qual Life Res. 2023 Aug;32(8):2361-2373. doi: 10.1007/s11136-023-03398-x. Epub 2023 Apr 3. Qual Life Res. 2023. PMID: 37010804 Free PMC article.
Triple combination of insulin glargine, sitagliptin and metformin in type 2 diabetes: the EASIE post-hoc analysis and extension trial.
Chan JC, Aschner P, Owens DR, Picard S, Vincent M, Dain MP, Pilorget V, Loizeau V, Echtay A, Fonseca V. Chan JC, et al. Among authors: aschner p. J Diabetes Complications. 2015 Jan-Feb;29(1):134-41. doi: 10.1016/j.jdiacomp.2014.08.007. Epub 2014 Aug 27. J Diabetes Complications. 2015. PMID: 25283485 Free article. Clinical Trial.
Insulin glargine compared with premixed insulin for management of insulin-naïve type 2 diabetes patients uncontrolled on oral antidiabetic drugs: the open-label, randomized GALAPAGOS study.
Aschner P, Sethi B, Gomez-Peralta F, Landgraf W, Loizeau V, Dain MP, Pilorget V, Comlekci A. Aschner P, et al. J Diabetes Complications. 2015 Aug;29(6):838-45. doi: 10.1016/j.jdiacomp.2015.04.003. Epub 2015 Apr 11. J Diabetes Complications. 2015. PMID: 25981123 Free article. Clinical Trial.
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.
Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, Josse R, Kaufman KD, Koglin J, Korn S, Lachin JM, McGuire DK, Pencina MJ, Standl E, Stein PP, Suryawanshi S, Van de Werf F, Peterson ED, Holman RR; TECOS Study Group. Green JB, et al. N Engl J Med. 2015 Jul 16;373(3):232-42. doi: 10.1056/NEJMoa1501352. Epub 2015 Jun 8. N Engl J Med. 2015. PMID: 26052984 Free article. Clinical Trial.
Continuous Glucose Monitoring Versus Capillary Point-of-Care Testing for Inpatient Glycemic Control in Type 2 Diabetes Patients Hospitalized in the General Ward and Treated With a Basal Bolus Insulin Regimen.
Gómez AM, Umpierrez GE, Muñoz OM, Herrera F, Rubio C, Aschner P, Buendia R. Gómez AM, et al. Among authors: aschner p. J Diabetes Sci Technol. 2015 Aug 31;10(2):325-9. doi: 10.1177/1932296815602905. J Diabetes Sci Technol. 2015. PMID: 26330394 Free PMC article.
Pancreatic Safety of Sitagliptin in the TECOS Study.
Buse JB, Bethel MA, Green JB, Stevens SR, Lokhnygina Y, Aschner P, Grado CR, Tankova T, Wainstein J, Josse R, Lachin JM, Engel SS, Patel K, Peterson ED, Holman RR; TECOS Study Group. Buse JB, et al. Among authors: aschner p. Diabetes Care. 2017 Feb;40(2):164-170. doi: 10.2337/dc15-2780. Epub 2016 Sep 14. Diabetes Care. 2017. PMID: 27630212 Free PMC article. Clinical Trial.
Effect of race on the glycaemic response to sitagliptin: Insights from the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS).
Davis TME, Mulder H, Lokhnygina Y, Aschner P, Chuang LM, Raffo Grado CA, Standl E, Peterson ED, Holman RR; TECOS Study Group. Davis TME, et al. Among authors: aschner p. Diabetes Obes Metab. 2018 Jun;20(6):1427-1434. doi: 10.1111/dom.13242. Epub 2018 Feb 28. Diabetes Obes Metab. 2018. PMID: 29405540 Clinical Trial.
Global status of diabetes prevention and prospects for action: A consensus statement.
Ibrahim M, Tuomilehto J, Aschner P, Beseler L, Cahn A, Eckel RH, Fischl AH, Guthrie G, Hill JO, Kumwenda M, Leslie RD, Olson DE, Pozzilli P, Weber SL, Umpierrez GE. Ibrahim M, et al. Among authors: aschner p. Diabetes Metab Res Rev. 2018 Sep;34(6):e3021. doi: 10.1002/dmrr.3021. Epub 2018 Jun 8. Diabetes Metab Res Rev. 2018. PMID: 29757486 Review.
91 results